The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study
Open Access
- 2 April 2025
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 223, 112119
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Open questions on basal insulin therapy in T2D: a Delphi consensusActa Diabetologica, 2024
- Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World StudyDiabetes Therapy, 2024
- Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 MonthsDiabetes Therapy, 2023
- Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of lifeBiomedicine & Pharmacotherapy, 2021
- Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine careDiabetes Research and Clinical Practice, 2021
- Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)Diabetes Therapy, 2020
- Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World PracticeDiabetes Therapy, 2020
- Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World SettingDiabetes Therapy, 2019
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical TrialDiabetes Therapy, 2016
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 DiabetesJAMA, 2016